Monitoring of illegal compounds and prohibited natural ingredients in foods |
Yun, Jisuk
(New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Choi, Jangduck (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kwon, Kisung (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Jo, Cheon-Ho (New Hazardous Substance Team, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) |
1 | Singh S, Prasad B, Savaliya AA, Shah RP, Gohil VM, Kqur A. Strategies for characterizing sildenafil, vardenafil, tadalafil, and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. Trac-Trend. Anal. Chem. 28: 13-28 (2009) DOI |
2 | Gur S, Kadowitz PJ, Gokce A, Sikka SC, Lokman U, Hellstrom WJG. Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension. Curr. Drug Metab. 14: 265-269 (2013). |
3 | Venhuis BJ, de Kaste D. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: A history, analytical aspects and health risks. J. Pharmaceut. Biomed. 69: 196-208 (2012) DOI |
4 | Shin MH, Hong MK, Kim WS, Lee YJ. Studies on the Sildenafils in Foods. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 459-465 (2002) |
5 | MFDS. Food Sanitation Law. Ministry of Food and Drug Safety. Cheongju, Korea. pp. 23-35 (2015) |
6 | Shin MH, Hong MK, Kim WS, Lee YJ, Jeoung YC. Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction. Food Addit. Contam. 20: 793-796 (2003) DOI |
7 | Shin C, Hong M, Kim D, Lim Y. Spectral assignments and reference data. Magn. Reson. Chem. 42: 1060-1062 (2004) DOI |
8 | MFDS. Food Code. Ministry of Food and Drug Safety. Cheongju, Korea. pp 39-44 (2015) |
9 | Patel DN, Low WL, Tan LL,Tan MM, Zhang Q, Low MY, Chan CL Koh HL. Adverse events associated with the use of complementary medicine and health supplements: An analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009. Clin. Toxicol. 50: 481-489 (2012) DOI |
10 | Poon WT, Lam YH, Lai CK, Chan AY, Mak TW. Analogues of erectile dysfunction drugs: An under-recognised threat. Hongkong Med. J. 13: 359-363 (2007) |
11 | Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: A retrospective review of the California poison control system reported cases. Clin. Toxicol. 47: 827-829 (2010) |
12 | MFDS. Monitoring and elucidation of novel illegal compounds in foods-about compounds relative to erectile dysfunction drugs and their analogues, steroids, etc. Ministry of Food and Drug Safety. Cheongju, Korea (2014). |
13 | Association of Official Analytical Chemists (AOAC). Appendix K: Guidelines for dietary supplements and botanicals. Available from: http://www.aoac.org/aoac_prod_imis/AOAC_Docs/StandardsDevelopment/eoma_appendix_k.pdf. Accessed May 11, 2016. |